Hepatic lipase activity is lower in african american men than in white american men: Effects of 5' flanking polymorphism in the hepatic lipase gene (LIPC)

Journal of Lipid Research

Volumn 39, Issue 1, 1998, Pages 228-232

  Vega, Gloria Lena ^a   Clark, Luther T ^b   Tang, Aylmer ^b   Marcovina, Santica ^c   Grundy, Scott M ^a   Cohen, Jonathan C ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

High density lipoprotein cholesterol

Indexed keywords

LIVER TRIACYLGLYCEROL LIPASE;

ADULT; ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DNA POLYMORPHISM; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME BLOOD LEVEL; GENETIC VARIABILITY; HUMAN; HYPERCHOLESTEROLEMIA; MALE; PRIORITY JOURNAL; RACE DIFFERENCE;

ADULT; AFRICAN CONTINENTAL ANCESTRY GROUP; ALLELES; CHOLESTEROL, HDL; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOTYPE; HEPARIN; HETEROZYGOTE; HOMOZYGOTE; HUMANS; LIPASE; LIVER; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; UNITED STATES;

EID: 0031929702     PISSN: 00222275     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Tyroler, H. A., C. J. Glueck, B. Christensen, and P.O. Kwiterovich, Jr. 1980. Plasma high-density lipoprotein cholesterol comparisons in black and white populations. The Lipid Research Clinics Program Prevalence Study. Circulation. 62: IV99-107.
2. Sprafka, J. M., S. W. Norsted, A. R. Folsom, G. L. Burke, and R. V. Luepker. 1992. Life-style factors do not explain racial differences in high-density lipoprotein cholesterol: the Minnesota Heart Survey. Epidemiology. 3: 156-163.
3. Webber, L. S., S. R. Srinivasan, W. A. Wattigney, and G. S. Berenson. 1991. Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am. J. Epidemiol. 133: 884-899.
4. Brown, S. A., R. Hutchinson, J. Morrisett, E. Boerwinkle, C. E. Davis, A. M. Gotto, Jr., and W. Patsch. 1993. Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler. Thromb. 13: 1139-1158.
5. Tikkanen, M. J., and E. A. Nikkila. 1987. Regulation of hepatic lipase and serum lipoproteins by sex steroids. [Review] Am. Heart J. 113: 562-567.
6. 2-cholesterol and increase hepatic triglyceride lipase activity. Med. Sci. Sports Exercise. 17: 462-465.
7. Applebaum-Bowden, D., S. M. Haffner, and W. R. Hazzard. 1987. The dyslipoproteinemia of anabolic steroid therapy: increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterol. Metabolism. 36: 949-952.
8. Masarei, J. R., and W. J. Lynch. 1977, Lowering of HDL-cholesterol by androgens [letter]. Lancet. 2: 827-828.
9. Cohen, J. C., W. M. Faber, A. J. Benade, and T. D. Noakes. 1986. Altered serum lipoprotein profiles in male and female powerlifters ingesting anabolic steroids. Phys. Sportsmed. 14: 131-136.
10. Alen, M., P. Rahkila, and J. Marniemi. 1985. Serum lipids in power athletes self-administering testosterone and anabolic steroids. Int. J. Sports Med. 6: 139-144.
11. Hurley, B. F., D. R. Seals, J. M. Hagberg, A. C. Goldberg, S. M. Ostrove, J. O. Holloszy, W. G. Wiest, and A. P. Goldberg. 1984. High-density-lipoprotein cholesterol in body-builders vs. powerlifters. Negative effects of androgen use. J. Am. Med. Assoc. 252: 507-513.
12. Guerra, R., J. P. Wang, S. M. Grundy, and J. C. Cohen. 1997. A hepatic lipase (LIPC) allele associated with high plasma concentrations of high density lipoprotein cholesterol. Proc. Natl. Acad. Sci. USA. 94: 4532-4537.
13. Blades, B., G. L. Vega, and S. M. Grundy. 1993. Activities of lipoprotein lipase and hepatic triglyceride lipase in postheparin plasma of patients with low concentrations of HDL choleslerol. Arterioscler. Thromb. 13: 1227-1235.
14. Applebaum-Bowden, D., S. M. Haffner, P. W. Wahl, J. J. Hoover, G. R. Warnick, J. J. Albers, and W. R. Hazzard. 1985. Postheparin plasma triglyceride upases. Relationships with very low density lipoprotein triglyceride and high density lipoprotein2 cholesterol. Arteriosclerosis. 5: 273-282.
15. Kuusi, T., P. Saarinen, and E. A. Nikkila. 1980. Evidence for the role of hepatic endothelial lipase in the metabolism of plasma high density lipoprotein2 in man. Atherosclerosis. 36: 589-593.
16. Jackson, R. L., M. T. Yates, C. A. McNerney, and M. L. Kashyap. 1990. Relationship between post-heparin plasma upases, triglycerides and high density lipoproteins in normal subjects. Hormone Metabol. Res. 22: 289-294.
17. Kuusi, T., C. Ehnholm, J. Viikari, R. Harkonen, E. Vartiainen, P. Puska, and M. R. Taskinen. 1989. Postheparin plasma lipoprotein and hepatic lipase are determinants of hypo-and hyperalphalipoproteinemia. J. Lipid Res. 30: 1117-1126.
18. Cohen, J. C., Z. Wang, S. M. Grundy, M. R. Stoesz and R. Guerra. 1994. Variation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels. J. Clin. Invest. 94: 2377-2384.
19. Hegele, R. A., J. A. Little, A. Vezina, C. F. Maguire, L. Tu, T. S. Wolever, D. J. Jenkins, and P. W. Connelly. 1993. Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics. Arterioscler. Thromb. 13: 720-728.
20. Shirai, K., R. L. Barnhart, and R. L. Jackson. 1981. Hydrolysis of human plasma high density lipoprotein 2-phospholipids and triglycerides by hepatic lipase. Biochem. Biophys. Res.Commun. 100: 591-599.
21. Jansen, H., and W. C. Hulsmann. 1985. Enzymology and physiological role of hepatic lipase. Biochem. Soc. Trans. 13: 24-26.
22. Busch, S. J., R. L. Barnhart, G. A. Martin, M. C. Fitzgerald, M. T. Yates, S. J. Mao, C. E. Thomas, and R. L. Jackson, 1994. Human hepatic triglyceride lipase expression reduces high density lipoprotein and aortic cholesterol in cholesterol-fed transgenic mice. J. Biol. Chem. 269: 16376-16382.
23. Fan, J., J. Wang, A. Bensadoun, S. J. Lauer, Q. Dang, R. W. Mahley, and J. M. Taylor. 1994. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. USA. 91: 8724-8728.